Edition:
United States

Alexandria Real Estate Equities Inc (ARE.N)

ARE.N on New York Stock Exchange

121.30USD
4:00pm EDT
Change (% chg)

$-0.76 (-0.62%)
Prev Close
$122.06
Open
$122.33
Day's High
$122.64
Day's Low
$121.18
Volume
292,775
Avg. Vol
222,147
52-wk High
$134.37
52-wk Low
$111.59

Summary

Name Age Since Current Position

Joel Marcus

69 2009 Chairman of the Board, President, Chief Executive Officer

Dean Shigenaga

50 2012 Chief Financial Officer, Executive Vice President, Treasurer

Stephen Richardson

55 2011 Chief Operating Officer, Regional Market Director - San Francisco

Thomas Andrews

57 2011 Executive Vice President, Regional Market Director – Greater Boston

Daniel Ryan

51 2012 Executive Vice President, Regional Market Director – San Diego and Strategic Operations

Peter Moglia

50 2009 Chief Investment Officer

Steven Hash

52 2016 Lead Independent Director

James Richardson

57 2009 Director,Senior Management Consultant

Michael Woronoff

2017 Director

John Atkins

73 2007 Independent Director

James Cain

59 2015 Independent Director

Maria Freire

63 2012 Independent Director

Richard Klein

61 2003 Independent Director

Biographies

Name Description

Joel Marcus

Mr. Joel S. Marcus J.D., CPA., has been appointed Chairman of the Board, President of Alexandria Real Estate Equities, Inc effective April 23, 2018. He co-founded Alexandria in 1994 as a garage startup with a business plan and $19 million in seed capital, and has led its growth into a publicly traded, investment-grade REIT. Alexandria has a total market capitalization of approximately $14.2 billion as of December 31, 2016, and significant market presence in key locations, including Greater Boston, San Francisco, New York City, San Diego, Seattle, Maryland, and Research Triangle Park. Mr. Marcus also founded the renowned Alexandria Summit, an invitation-only gathering of the world's foremost visionaries from the biopharmaceutical, medical, academic, and financial philanthropic, advocacy, and government communities, to address the most critical global healthcare challenges. Prior to co-founding Alexandria, Mr. Marcus had an extensive law career specializing in corporate finance and capital markets, venture capital, and mergers and acquisitions, with a unique expertise in the biopharmaceutical industry. He was one of the principal architects of the Kirin-Amgen EPO joint venture in 1984. He was also formerly a practicing certified public accountant and tax manager with Arthur Young & Co., focusing on the financing and taxation of REITs. Mr. Marcus serves on the board of directors of Atara Biotherapeutics, Inc. (NASDAQ: ATRA), a clinical-stage biopharmaceutical company which completed its initial public offering in October 2014, Foundation for the National Institutes of Health (FNIH), and Intra-Cellular Therapies, Inc. (NASDAQ: ITCI). Mr. Marcus is a recipient of the Ernst & Young Entrepreneur of the Year Award (Los Angeles - Real Estate). He received his undergraduate and Juris Doctor degrees frofrom the University of California, Los Angeles.

Dean Shigenaga

Mr. Dean A. Shigenaga has been appointed Co-President, Chief Financial Officer of the Company effective April 23, 2018. Mr. Shigenaga joinedAlexandriain 2000 and has served as the company's chief financial officer (CFO) since 2004. He is a certified public accountant with nearly 25 years of accounting and real estate experience. For the past 13 years as CFO, Mr. Shigenaga has effectively led the company's financial, accounting and treasury functions and in doing so has developed one of the best teams in the country. He and his team were the architects ofAlexandria'saward-winning disclosures and reporting, which were recognized by Nareit with the Investor CARE (Communications and Reporting Excellence) Gold Award in 2015 and 2016. Over the past decade, Mr. Shigenaga has been instrumental in the disciplined management of the company's balance sheet and the significant improvement in its credit profile to its current best position in the company's history.Alexandria'slatest corporate credit rating of BBB with a positive outlook from S&P Global Ratings, combined with the continued disciplined management of its balance sheet, will support the company's strategic long-term growth initiatives. As co-president, Mr. Shigenaga will add to his leadership responsibilities related to strategic operations.

Stephen Richardson

Mr. Stephen A. Richardson has been appointed as Co-Chief Executive Officer effective April 23, 2018. Mr. Richardson joined Alexandriain 2000 and has served as the company's chief operating officer since 2011. He has also guided the management and growth of all aspects of the San Francisco region since 2005, including leading and growing the respected regional team; maintaining and deepening key real estate, life science, technology and government relationships; and driving and participating in key strategic acquisitions over the years, most notably the 2004/2005 acquisition of land parcels and related entitlements to develop 1.4 million SF of state-of-the-art office/laboratory space in Mission Bay,San Francisco. Mr. Richardson played a meaningful role in the company's early recognition of the cross-pollination of life science and technology companies and in leveraging the trend to drive demand for its urban innovation cluster campuses. With his long-term focus on the company's strategic planning and revenue growth, Mr. Richardson is a crucial member of Alexandria's executive management team. In his new role as co-chief executive officer, he will assume additional leadership responsibilities.

Thomas Andrews

Mr. Thomas J. Andrews has been appointed Co-President and Regional Market Director – Greater Boston of the Company effective April 23, 2018. Mr. Andrews has been responsible for the management of the company's Greater Bostonasset base and operations since joining Alexandriain 1999. During his more than 18-year tenure, he has steered the transformative growth of the Greater Boston region into the company's largest region, which is home to three of Alexandria'smost prominent life science and technology campuses in the heart of Cambridge. As regional market director, Mr. Andrews has led the strategic acquisition of multiple, value-added properties; diligently managed on-time, on-budget development projects; and cultivated and maintained key tenant relationships. He has also built and guides a highly skilled team across a range of disciplines with operational excellence. Leveraging nearly 30 years of experience in the commercial real estate industry, a proven track record of leading the expansive Greater Boston region and a well-respected reputation within the real estate, life science and technology communities, Mr. Andrews will assume additional responsibilities related to the company's overall strategic operations.

Daniel Ryan

Mr. Daniel J. Ryan served as Executive Vice President – Regional Market Director – San Diego and Strategic Operations since May 2012. He previously served as the Company’s Senior Vice President – Regional Market Director (San Diego) & Strategic Operations from June 2010, when the Company acquired certain assets of Mr. Ryan’s company, Veralliance Properties, Inc. (“Veralliance”), to May 2012. During his tenure with the Company, Mr. Ryan has been responsible for the management of the Company’s San Diego region asset base and operations, as well as involvement with developments, redevelopments, joint ventures, financing, leasing, and other strategic opportunities outside the San Diego region. Prior to joining the Company, Mr. Ryan was Chief Executive Officer of Veralliance, a commercial real estate developer, which he founded in 2002. Veralliance owned, managed, developed, and leased an approximately $1 billion portfolio primarily consisting of life science assets in the greater San Diego region. Veralliance had significant institutional equity partners, including a REIT, Prudential Real Estate Investors, and UBS. Prior to 2002, He was a founding principal of Pacific Management Services, Inc., a commercial developer focused on value-added transactions in the greater San Diego area, including life science, office, industrial, and multifamily transactions. Mr. Ryan is a board member of BIOCOM, a Southern California trade organization, the San Diego Economic Development Corporation, a not-for-profit regional body comprising of business, government, and civic leaders committed to maximizing economic growth, and the Policy Advisory Board of the University of San Diego – School of Real Estate. He is also a member of the NAIOP and the Urban Land Institute, both public policy organizations focused on public advocacy of the built environment. Mr. Ryan received his Bachelor of Science degree in Economics, cum laude, from the University of Wisconsin.

Peter Moglia

Mr. Peter M. Moglia has been appointed Co-Chief Executive Officer, Chief Investment Officer of the Company effective April 23, 2018. Since joining Alexandriain 1998, Mr. Moglia has served the company in many important roles of increasing scope and responsibility, most recently as chief investment officer overseeing the company's strategic growth through a focus on acquisitions and dispositions, development and redevelopment, leasing and joint ventures. He also concurrently leads Alexandria' sreal estate finance team, which provides critical support across a range of underwriting, due diligence and financing activities. During his two-decade career at Alexandria, Mr. Moglia has been very instrumental in the company's disciplined allocation of capital and has directed pivotal, value-added acquisitions, including the Alexandria Center ® for Life Science -New York City, the Illumina campus in San Diegoand the Alexandria Center ® at One Kendall Square in Cambridge. Prior to his role as chief investment officer, he managed the company's Seattleasset base and operations from 2003 through 2008, during which time the region doubled its revenue. As a real estate veteran with extensive industry and market knowledge, Mr. Moglia has directly contributed to Alexandria's strong performance and is well positioned to assume the additional responsibilities of co-chief executive officer.

Steven Hash

Mr. Hash R.Stevenis is Lead Independent Director of Alexandria Real Estate Equities Inc, He is the President and Chief Operating Officer of Renaissance Macro Research, LLC, an equity research and trading firm focused on macro research in the investment strategy, economics, and Washington policy sectors, which he co-founded in 2012. Between 1993 and 2012, Mr. Hash held various leadership positions with Lehman Brothers (and its successor, Barclays Capital), including Global Head of Real Estate Investment Banking from 2006 to 2012, Chief Operating Officer of Global Investment Banking from 2008 to 2011, Director of Global Equity Research from 2003 to 2006, Director of U.S. Equity Research from 1999 to 2003, and Senior Equity Research Analyst from 1993 to 1999. From 1990 to 1993, Mr. Hash held various positions with Oppenheimer & Company’s Equity Research Department, including senior research analyst. He began his career in 1988 as an auditor for the accounting and consulting firm of Arthur Andersen & Co. He has served as a director of The Macerich Company (NYSE: MAC) since May 2015. Mr. Hash received a Bachelor of Arts degree in Business Administration from Company (NYSE: MAC) since May 2015. Mr. Hash received a Bachelor of Arts degree in Business Administration from Loyola University and a Master of Business Administration degree from the Stern School of Business at New York University. Mr. Hash’s qualifications to serve on the Board of Directors include his financial expertise and extensive knowledge of the real estate industry, which he acquired from various positions, including his former position as Global Head of Real Estate Investment Banking with Lehman Brothers (and its successor, Barclays Capital) and current position as President and Chief Operating Officer of Renaissance Macro Research, LLC.

James Richardson

Mr. James H. Richardson is Director of Alexandria Real Estate Equities, Inc., since March 1999. He has served the Company as a senior management consultant since February 2009, President of the Company from August 1998 to February 2009, a director since March 1999, and in other capacities from August 1997 to August 1998. Prior to joining the Company, Mr. Richardson held management and brokerage positions for nearly 15 years at CB Richard Ellis, Inc., a full-service provider of commercial real estate services. He was a top producer within the brokerage services group as well as a senior leader responsible for strategy and operations. During his time at CB Richard Ellis, Inc., Mr. Richardson was instrumental in the creation and development of the biosciences and corporate services practice groups. Mr. Richardson received his Bachelor of Arts degree in Economics from Claremont McKenna College. Mr. Richardson’s qualifications to serve on the Board of Directors include his expertise in leasing, financing, strategic planning, operations, and other matters involving the life science and real estate industries, which he acquired in his more than 15 years of experience as President and a director of the Company and his previous nearly 15 years of experience in brokerage and management positions with CB Richard Ellis, Inc., a top-tier real estate services firm. He also currently serves in board and advisory positions for private real estate development and investment enterprises, as well as early-stage technology and product companies.

Michael Woronoff

Mr. Michael A. Woronoff serves as Director of the company. Mr. Woronoff has been a partner of Proskauer Rose LLP (“Proskauer”) since 2004 and currently serves as the head of Proskauer’s Los Angeles office and west coast corporate and securities practice. Mr. Woronoff is also co-head of Proskauer's global private equity group. Mr. Woronoff advises clients on public and private debt and equity financings, restructuring transactions, and corporate and securities law matters, including SEC reporting, corporate governance and strategic alliances. From 2000 to 2004, prior to joining Proskauer, Mr. Woronoff was a principal of Shelter Capital Partners, a Southern California-based private equity fund that invests in technology and technology-enabled businesses at all stages of development. He received a Juris Doctor degree from the University of Michigan Law School, a Master of Science in Industrial Administration degree from Krannert Graduate School of Management at Purdue University, and a Bachelor of Science in Industrial Management degree from Purdue University.

John Atkins

Mr. John L. Atkins, III, is Independent Director of Alexandria Real Estate Equities, Inc., since March 2007. He a licensed architect, is Chairman and Chief Executive Officer of O’Brien/Atkins Associates, PA, a multidisciplinary design services firm that he co-founded in Research Triangle Park, North Carolina, in 1975. Mr. Atkins has previously served as Chairman of the North Carolina Board of Architecture and was named an Emeritus Member of that board in 1988. Mr. Atkins was elevated in 1991 to the American Institute of Architects’ College of Fellows, an honor only 5% of architects receive. Mr. Atkins is immediate past Chairman of the North Carolina Biotechnology Center and currently serves as a Director and Executive Committee member. He is past Chairman of the North Carolina Railroad Company and is a director of the Kenan Institute for Engineering, Technology & Science, based at North Carolina State University. In 2005, Mr. Atkins was awarded the American Institute of Architects-North Carolina Chapter’s F. Carter Williams Gold Medal, the Chapter’s highest individual honor, in recognition of his distinguished career, and was named the 2005 College of Design’s Distinguished Alumnus by North Carolina State University. In 2003, Mr. Atkins also received the Watauga Medal, the highest nonacademic honor bestowed by North Carolina State University in honor of individuals who have made significant contributions to the university’s advancement. Mr. Atkins holds a Bachelor of Architecture degree from North Carolina State University and a Master of Regional Planning degree from the University of North Carolina at Chapel Hill. Mr. Atkins’s qualifications to serve on the Board of Directors include his extensive knowledge and experience as a licensed architect and his experience as co-founder of a multidisciplinary design services firm with expertise in the site selection, design, and construction of life science buildings, as well as his broad management and business experience.

James Cain

Amb. James P. Cain is Independent Director of the Company. He is the managing partner of Cain Global Partners, LLC, a company that provides a vital link between the developed and emerging markets of the world by utilizing its network of diplomatic, political, and corporate resources. As a partner at Cain Global Partners, Ambassador Cain works with North American and European companies to expand their operations into international markets (such as Asia, Latin America, Eastern Europe, and the Middle East), as well as to support economic development and public policy interests. His career has spanned the fields of leadership, law, business, sports, and international diplomacy, and he has mastered the skills of building lasting relationships as well as strong ecosystems. Ambassador Cain’s unique combination of expertise and passion for business and leadership has been instrumental in his role in developing the Research Triangle Park innovation cluster. For 20 years, Ambassador Cain was a partner at the international law firm of Kilpatrick Townsend & Stockton LLP (formerly known as Kilpatrick Stockton), where he co-founded the firm’s Raleigh office in 1985. He continues to serve as counsel to Kilpatrick Townsend & Stockton. From 2000 to 2002, Ambassador Cain served as the president and chief operating officer of the NHL Carolina Hurricanes and their parent company, Gale Force Holdings. Later, during his tenure as the U.S. Ambassador to Denmark, a position for which he was nominated by President George W. Bush on June 30, 2005 (to serve until January 2009), Ambassador Cain called upon not only his leadership and relationship-building skills, but also his experience from his time working with the Carolina Hurricanes. As Ambassador, he oversaw the 13 agencies of the American government that composed the U.S. Embassy in Copenhagen, where he focused his energies on areas of national security, counter-terrorism, energy security, commerce, and investment.

Maria Freire

Dr. Maria C. Freire, Ph.D., is an Independent Director of Alexandria Real Estate Equities, Inc., effective April 20, 2012. In November 2012, Dr. Freire became the President and Executive Director, and a member of the Board of Directors, of the Foundation for the National Institutes of Health (“FNIH”), a Congressionally-authorized independent organization that draws together the world’s foremost researchers and resources in support of the mission of the National Institutes of Health (“NIH”). Prior to her appointment to the FNIH, Dr. Freire was the President and a member of the Board of Directors of the Albert and Mary Lasker Foundation, a non-profit organization that bestows the Lasker Awards in basic and clinical science and advocates for medical research. From 2001 to 2008, Dr. Freire served as President and Chief Executive Officer of the Global Alliance for TB Drug Development, a public-private partnership that develops better, faster-acting, and affordable drugs to fight tuberculosis. An expert in technology commercialization, she directed the Office of Technology Transfer at the NIH from 1995 to 2001 and served as a commissioner on the World Health Organization’s Commission on Intellectual Property Rights, Innovation and Public Health. Dr. Freire obtained her Bachelor of Science degree from the Universidad Peruana Cayetano Heredia in Lima, Peru, and her Ph.D. in Biophysics from the University of Virginia; she completed post graduate work in Immunology and Virology at the University of Virginia and the University of Tennessee. She was on the Science Board of the Food and Drug Administration (FDA) and a member of the Commission on a Global Health Risk Framework for the Future of the Institute of Medicine, among others. Her awards include the Department of Health and Human Services Secretary’s Award for Distinguished Service, the Arthur S. Flemming Award, and the Bayh-Dole Award. Dr. Freire is a member of the U.S. National Academy of Medicine and the Council on Foreign Relations.

Richard Klein

Mr. Richard H. Klein is Independent Director of Alexandria Real Estate Equities, Inc., since December 2003. He has a diverse background for more than 30 years as a senior advisor to a variety of domestic and international businesses, with a particular focus on real estate organizations. He currently serves as Chief Financial Officer of Industrial Realty Group, LLC, a privately held owner and developer of commercial and industrial properties with a 110 million square foot portfolio located throughout the United States. From 2012 to 2015, Mr. Klein served as an independent business consultant. In 2003, Mr. Klein founded Chefmakers Cooking Academy LLC, which provided culinary education services and experiences and for which he served as Chief Executive Officer through 2011. From 1984 to 2000, Mr. Klein was with Ernst & Young LLP, and a predecessor firm, Kenneth Leventhal & Company. From 1978 to 1983, Mr. Klein provided tax consulting and auditing services for PricewaterhouseCoopers LLP. At these firms, Mr. Klein served in a variety of capacities, including as partner in the REIT Advisory Practice, the Financial Restructuring and Insolvency Practice, and the Public Relations and Practice Development Department. Mr. Klein is a certified public accountant in the State of California. He received his Bachelor of Science degree in Accounting and Finance from the University of Southern California. Mr. Klein’s qualifications to serve on the Board of Directors include his extensive experience and knowledge of the real estate industry and REITs in particular and the accounting and financial expertise he developed as a certified public accountant and partner of Ernst & Young LLP.

Basic Compensation

Name Fiscal Year Total

Joel Marcus

3,640,060

Dean Shigenaga

5,656,120

Stephen Richardson

5,341,120

Thomas Andrews

6,681,180

Daniel Ryan

2,596,050

Peter Moglia

4,929,620

Steven Hash

342,818

James Richardson

235,513

Michael Woronoff

--

John Atkins

275,060

James Cain

246,060

Maria Freire

276,763

Richard Klein

295,060
As Of  30 Dec 2016